Long, G. V., Tykodi, S. S., Schneider, J. G., Garbe, C., Gravis, G., Rashford, M., . . . Zhao, X. (2018). Assessment of nivolumab exposure and clinical safety of 480 mg every 4 weeks flat-dosing schedule in patients with cancer. Ann Oncol.
Citação norma ChicagoLong, G V., et al. "Assessment of Nivolumab Exposure and Clinical Safety of 480 mg Every 4 Weeks Flat-dosing Schedule in Patients With Cancer." Ann Oncol 2018.
MLA CitationLong, G V., et al. "Assessment of Nivolumab Exposure and Clinical Safety of 480 mg Every 4 Weeks Flat-dosing Schedule in Patients With Cancer." Ann Oncol 2018.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.